Category Archives: Cancer: Multiple Myeloma

Excess weight linked to 8 more cancer types






Newswise — There’s yet another reason to maintain a healthy weight as we age. An international team of researchers has identified eight additional types of cancer linked to excess weight and obesity: stomach, liver, gall bladder, pancreas, ovary, meningioma (a … Continue reading






Posted in Cancer: Brain, Cancer: Gall Bladder, Cancer: Liver, Cancer: Multiple Myeloma, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Stomach, Cancer: Thyroid, Obesity | Leave a comment

As Body Mass Index Increases, So Does Spread of Multiple Myeloma






Newswise — In a new study published in Cancer Letters, American University researchers show how, as body mass index increases, so does the growth and spread of the blood cancer multiple myeloma, which accounts for about 10 percent of all … Continue reading






Posted in Cancer: Multiple Myeloma | Leave a comment

Low Intensity Vibration Mitigates Tumor Progression and Protect Bone Quantity and Quality in a Murine Model of Myeloma






Bone. 2016 Jun 1. pii: S8756-3282(16)30150-8. doi: 10.1016/j.bone.2016.05.014. [Epub ahead of print] Low Intensity Vibration Mitigates Tumor Progression and Protect Bone Quantity and Quality in a Murine Model of Myeloma. Pagnotti GM1, Chan ME1, Adler BJ1, Shroyer KR2, Rubin J3, … Continue reading






Posted in Cancer: Multiple Myeloma | Comments Off on Low Intensity Vibration Mitigates Tumor Progression and Protect Bone Quantity and Quality in a Murine Model of Myeloma

For multiple myeloma, FDA approves Ninlaro, new oral medication






Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy. Multiple myeloma is a form of blood cancer … Continue reading






Posted in Cancer: Multiple Myeloma | Comments Off on For multiple myeloma, FDA approves Ninlaro, new oral medication

Father’s age linked to risk of blood cancer as an adult; particularly strong among only children: American Cancer Society






A new study links a father’s age at birth to the risk that his child will develop blood and immune system cancers as an adult, particularly for only children. The study, which appears in the American Journal of Epidemiology, found … Continue reading






Posted in Cancer: Leukemia, Cancer: Lymphoma, Cancer: Multiple Myeloma, Immune System | Comments Off on Father’s age linked to risk of blood cancer as an adult; particularly strong among only children: American Cancer Society

Multiple myeloma and myeloid leukemia therapies could be enhanced with experimental drug






A pre-clinical study led by Virginia Commonwealth University Massey Cancer Center and Department of Internal Medicine researchers suggests that an experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies. The study, recently … Continue reading






Posted in Cancer: Leukemia, Cancer: Multiple Myeloma | Comments Off on Multiple myeloma and myeloid leukemia therapies could be enhanced with experimental drug

Alcohol consumption tied to reduced cancer risk in new, large study






Cancer Epidemiol Biomarkers Prev. 2013 Aug 20. [Epub ahead of print] A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium. Andreotti G, Birmann B, De Roos AJ, Spinelli J, Cozen W, Camp … Continue reading






Posted in Alcohol, Cancer: Multiple Myeloma | Comments Off on Alcohol consumption tied to reduced cancer risk in new, large study

Multiple myeloma drug Kyprolis gets FDA approval






The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises … Continue reading






Posted in Cancer: Multiple Myeloma | Comments Off on Multiple myeloma drug Kyprolis gets FDA approval

Why chemo fails






The fight against cancer is not won in a single battle: Long after a cancer has been beaten into remission, it can return. The reason for this is under debate, and much is unclear. New research led by Weizmann Institute … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bile Duct, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chemo Brain, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Stomach, Cancer: Testicular, Cancer: Throat, Cancer: Thyroid, Cancer: Uterine, Chemotherapy | Comments Off on Why chemo fails

Cancer diagnostic test that may extend survival is cost effective: J Natl Cancer Inst






REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, announced today that results from a study involving its Pathwork® Tissue of Origin Test will be presented this week at the … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Stomach, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval, Health Care: Technology | Comments Off on Cancer diagnostic test that may extend survival is cost effective: J Natl Cancer Inst

Cancer detection at inception goal of new grant






Newswise — A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers. Using advanced imaging tools developed … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cell Phones, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Stomach, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off on Cancer detection at inception goal of new grant

Advanced melanoma vaccine improves response rate, survival: first cancer vaccine to show an improved response rate in patients: NEJM






A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off on Advanced melanoma vaccine improves response rate, survival: first cancer vaccine to show an improved response rate in patients: NEJM

Multiple myeloma survival improves with stem-cell transplant followed by lenalinomide: clinical trial conducted by the Cancer and Leukemia Group (CALGB)






Updated data from a National Cancer Institute-sponsored clinical trial conducted by the Cancer and Leukemia Group (CALGB) was presented May 5 at the 13th International Myeloma Workshop in Paris, France. The phase III study evaluated the benefits of continuous, or … Continue reading






Posted in Cancer: Multiple Myeloma, Stem Cells | Comments Off on Multiple myeloma survival improves with stem-cell transplant followed by lenalinomide: clinical trial conducted by the Cancer and Leukemia Group (CALGB)

Cancer survivors number 12,000,000 in US






The number of cancer survivors in the United States increased to 11.7 million in 2007, according to a report released by the Centers for Disease Control and Prevention and the National Cancer Institute (NCI), part of the National Institutes of … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off on Cancer survivors number 12,000,000 in US

What all cancers have in common, updated






Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC) have updated their seminal review, “Hallmarks of Cancer,” which has influenced the study of cancer and … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off on What all cancers have in common, updated

Cancer breakthrough may be possible with nanomedicine discovery






Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication’s toxic effects will no longer be an oncologist’s dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of … Continue reading






Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval, Nanotechnology and Health | Comments Off on Cancer breakthrough may be possible with nanomedicine discovery

Multiple myeloma patient lives extended by zoledronic acid: UK research






Zoledronic acid (Zometa, Reclast) extends survival in patients with multiple myeloma, researchers reported. In a randomized but not blinded trial, patients getting zoledronic acid in addition to standard anti-myeloma therapy lived a median of 5.5 months longer than those getting … Continue reading






Posted in Cancer: Multiple Myeloma | Tagged , , , , , , , | Comments Off on Multiple myeloma patient lives extended by zoledronic acid: UK research